Beijing Airdoc Technology Co., Ltd. (HKG:2251)

Market Cap	1.24B
Revenue (ttm)	166.40M
Net Income (ttm)	-271.85M
Shares Out	102.14M
EPS (ttm)	-2.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	50,628
Open	12.18
Previous Close	12.16
Day's Range	12.14 - 12.18
52-Week Range	10.00 - 15.24
Beta	0.75
RSI	49.03
Earnings Date	May 28, 2025

About Beijing Airdoc Technology

Beijing Airdoc Technology Co., Ltd. focuses on the provision of artificial intelligence (AI) empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally. The company offers a software as a medical device (SaMD) product, Airdoc-AIFUNDUS, which is an AI-assisted diagnosis of retinal detection product that is available in three versions comprising version 1.0 for the diagnosis of diabetic retinopathy, version 2.0 that address a wide range of fundus diseases, and version 3.0 for the ...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 282
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2251

Financial Performance

In 2024, Beijing Airdoc Technology's revenue was 156.37 million, a decrease of -23.34% compared to the previous year's 203.96 million. Losses were -255.46 million, 92.8% more than in 2023.

Financial numbers in CNY